Oncology Tube Interview with Dr. David Lieberman, OHSU
Dr. David Lieberman discusses the Geneoscopy: Efficacy of Non-Invasive Colorectal Cancer Screening Test Evaluated in the CRC-PREVENT Phase 3 Trial
Dr. David Lieberman discusses the Geneoscopy: Efficacy of Non-Invasive Colorectal Cancer Screening Test Evaluated in the CRC-PREVENT Phase 3 Trial
“As leaders, we have a responsibility to come together to impact cancer. Colorectal cancer is one of the most preventable and treatable cancers when diagnosed
“Embrace your flaws: Everyone has flaws. I feel that I have been successful because I am able to recognize these flaws, understand where I need
Adds CAP Accreditation to Clinical Laboratory Improvement Amendments (CLIA) certification ST. LOUIS, Dec. 14, 2022 / — Geneoscopy, Inc., a life sciences company focused on
Originally published July 1, 2022 Haytham Gareer, MD, PhD, MBA, FACS for Pharmacy Times Nearly 63% of newly diagnosed patients have advanced colorectal cancer,